Progresses of researches on the correlation between pregnane X receptor and CYP3A

Chinese Journal of Pharmacology and Toxicology

Volumn 17, Issue 3, 2003, Pages 235-240

  Sun, Jian Han ^a   Zhu, Xin Qiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cytochrome P450; Receptors, pregnane

Indexed keywords

CYTOCHROME P450 3A; GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; PREGNANE X RECEPTOR; STEROID;

ARTICLE; CORRELATION ANALYSIS; DRUG USE; ENZYME INDUCTION; GENE EXPRESSION REGULATION; LIGAND BINDING; LIVER; MEDICAL RESEARCH; PREDICTION; PROTEIN DOMAIN; PROTEIN FUNCTION; SPECIES DIFFERENCE; STEROID METABOLISM; UPREGULATION;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0038267066     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wang JS, Xu ZH, Zhou HH. Cytochrome P450 3A4 and drug metabolism[J]. Chin J Clin Pharmacol, 1996, 12(4):231-235.
2. Peng H, Cheng ZN. Drug interaction related to CYP3A4 [J]. Chin J Clin Pharmacol, 2001, 17(5):379-385.
3. Masuyama H, Hiramatsu Y, Mizutani Y, Inoshita H, Kudo T. The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse[J]. Mol Cell Endocrinol, 2001, 172(1-2):47-56.
4. LeCulyse EL. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics[J]. Chem Biol Interact, 2001, 134(3):283-289.
5. Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions[J]. Toxicology, 2000, 153(1-3):1-10.
6. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity [J]. Proc Natl Acad Sci USA, 2001, 98(6):3369-3374.
7. Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids[J]. Proc Natl Acad Sci USA, 2001, 98(6):3375-3380.
8. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition[J]. Clin Pharmacokinet, 2000, 38(1):41-57.
9. Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, et al. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos[J]. J Pharmacol Exp Ther, 2001, 299(3):825-831.
10. Maurel P. The CYP3 family[A]. In: Ioannides C, eds. Cytochromes P450: Metabolic and Toxicological Aspects [M]. Boca Raton: CRC Press, Inc., 1996. 241-270.
11. Quattrochi LC, Guzelian PS. CYP3A regulation: from pharmacology to nuclear receptors[J]. Drug Metab Dispos, 2001, 29(5):615-622.
12. Takeshita A, Koibuchi N, Oka J, Taguchi M, Shishiba Y, Ozawa Y. Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription[J]. Eur J Endocrinol, 2001, 145(4):513-517.
13. Westlind A, Lofberg L, Tindberg N, Andersson TB, Ingelman-Sundberg M. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region[J]. Biochem Biophys Res Commun, 1999, 259(1):201-205.
14. Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4 * 1B5′-promoter region polymorphism[J]. Clin Pharmacol Ther, 2000, 68(1):82-91.
15. Kliewer SA, Moore JT, Wade L, Staudinger JT, Watson MA, Jones MA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway [J]. Cell, 1998, 192(1):73-82.
16. Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, et al. Pregnane X receptor(PXR), constitutive androstane receptor(CAR), and benzoate X receptor(BXR) define three pharmacologically distinct classes of nuclear receptors[J]. Mol Endocrinol, 2002, 16(5): 977-986.
17. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor[J]. Genes Dev, 1998, 12 (20):3195-3205.
18. Xie W, Evans RM. Pharmaceutical use of mouse models humanized for the xenobiotic receptor[J]-Drug Discov Today, 2002, 7(9):509-515.
19. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions[J]. J Clin Invest, 1998, 102(5):1016-1023.
20. Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, et al. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants[J]. Pharmacogenetics, 2001, 11 (7):555-572.
21. Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, et al. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation[J]. Arch Biochem Biophys, 1999, 368(1):14-22.
22. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity[J]. Science, 2001, 292(5525):2329-2333.
23. Ekins S, Schuetz E. The PXR crystal structure: the end of the beginning[J]. Trends Pharmacol Sci, 2002, 23(2): 49-50.
24. Forman BM. Polymorphisms in promiscuous PXR: an explanation for interindividual differences in drug clearance[J]? Pharmacogenetics, 2001, 11(7):551-552.
25. Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, et al. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4 [J]. Drug Metab Dispos, 2001, 29(11):1454-1459.
26. Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, et al. CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes[J]. Drug Metab Dispos, 2002, 30(7):795-804.